SCHEMBL9258726

SCHEMBL9258726

c1ccc2c(c1)-c1ncnn1Cc1c(-c3nc(C4CC4)no3)ncn1-2

nearest known ligand 0.60

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GABRG2 P18507 12/20 0.55
GABRB3 P28472 12/20 0.55
GABRA5 P31644 12/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9266435 0.88 GABRG2 (0.59) GABRG2GABRB3GABRA5
SCHEMBL9268520 0.87 GABRG2 (0.65) GABRG2GABRB3GABRA5
SCHEMBL9259079 0.87 GABRG2 (0.66) GABRG2GABRB3GABRA5
SCHEMBL9268572 0.86 GABRG2 (0.59) GABRG2GABRB3GABRA5
SCHEMBL9260584 0.85 GABRG2 (0.55) GABRG2GABRB3GABRA5
SCHEMBL6866468 0.85 GABRG2 (0.47) GABRG2GABRB3GABRA5
SCHEMBL9265109 0.83 GABRG2 (0.41) GABRG2GABRB3GABRA5
SCHEMBL9262828 0.82 GABRA1 (0.61) GABRG2GABRB3GABRA5
SCHEMBL9375606 0.79
SCHEMBL8866427 0.77 GRM5 (0.46) GABRG2GABRB3GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5387585-A Treating epilepsy, anxiety, sleep disorders, schizophrnia, senile dementia HOFFMANN-LA ROCHE INC. (US) 1995-02-07 US claimed
EP-0519307-A2 Tetracyclic Imidazodiazepines F. HOFFMANN-LA ROCHE AG (CH) 1992-12-23 EP claimed
US-5387585-A Treating epilepsy, anxiety, sleep disorders, schizophrnia, senile dementia HOFFMANN-LA ROCHE INC. (US) 1995-02-07 US disclosed
EP-0519307-A2 Tetracyclic Imidazodiazepines F. HOFFMANN-LA ROCHE AG (CH) 1992-12-23 EP disclosed